Theodore E Hebert
Examiner (ID: 6600, Phone: (571)270-1409 , Office: P/2199 )
Most Active Art Unit | 2199 |
Art Unit(s) | 2198, 2199 |
Total Applications | 481 |
Issued Applications | 338 |
Pending Applications | 58 |
Abandoned Applications | 84 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17952483
[patent_doc_number] => 11478558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
[patent_app_type] => utility
[patent_app_number] => 16/617244
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 36
[patent_no_of_words] => 28593
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617244 | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer | May 29, 2018 | Issued |
Array
(
[id] => 16569224
[patent_doc_number] => 20210008230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TARGETED MICROBUBBLE, PREPARATION METHOD THEREOF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/968766
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968766 | TARGETED MICROBUBBLE, PREPARATION METHOD THEREOF, AND USE THEREOF | Apr 25, 2018 | Abandoned |
Array
(
[id] => 16762375
[patent_doc_number] => 20210107956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ULTRASENSITIVE DETECTION PLATFORM USING LUMINESCENT METALS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/500482
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500482 | ULTRASENSITIVE DETECTION PLATFORM USING LUMINESCENT METALS AND USES THEREOF | Apr 2, 2018 | Pending |
Array
(
[id] => 15708497
[patent_doc_number] => 20200101014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles
[patent_app_type] => utility
[patent_app_number] => 16/494719
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494719 | Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles | Apr 1, 2018 | Abandoned |
Array
(
[id] => 16761117
[patent_doc_number] => 20210106698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => LIVER-SPECIFIC MRI CONTRAST AGENT INCLUDING MANGANESE SILICATE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/498376
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498376 | LIVER-SPECIFIC MRI CONTRAST AGENT INCLUDING MANGANESE SILICATE NANOPARTICLES | Mar 29, 2018 | Pending |
Array
(
[id] => 13458011
[patent_doc_number] => 20180280548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => GAS-GENERATING POLYMER MICELLS AND MANUFACTURING METHOD OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/933143
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933143 | Gas-generating polymer micells and manufacturing method of the same | Mar 21, 2018 | Issued |
Array
(
[id] => 16581545
[patent_doc_number] => 20210015947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => CONTRAST MEDIUM FOR MICROANGIOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 16/491866
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491866 | CONTRAST MEDIUM FOR MICROANGIOGRAPHY | Mar 5, 2018 | Pending |
Array
(
[id] => 12904408
[patent_doc_number] => 20180193311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/912438
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912438 | Sustained release pharmaceutical compositions | Mar 4, 2018 | Issued |
Array
(
[id] => 16523843
[patent_doc_number] => 20200397923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => HYPERPOLARISATION IN AQUEOUS MEDIA VIA SABRE
[patent_app_type] => utility
[patent_app_number] => 16/491814
[patent_app_country] => US
[patent_app_date] => 2018-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491814 | HYPERPOLARISATION IN AQUEOUS MEDIA VIA SABRE | Mar 2, 2018 | Pending |
Array
(
[id] => 16189041
[patent_doc_number] => 20200229890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => SURGICAL VISUALIZATION AND MEDICAL IMAGING DEVICES AND METHODS USING NEAR INFRARED FLUORESCENT POLYMERS
[patent_app_type] => utility
[patent_app_number] => 16/485976
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485976 | Surgical visualization and medical imaging devices and methods using near infrared fluorescent polymers | Feb 15, 2018 | Issued |
Array
(
[id] => 13357285
[patent_doc_number] => 20180230182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => HYPERPOLARIZATION OF AMINO ACID RESIDUES FOR PRODUCING HYPERPOLARIZED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/897462
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897462 | HYPERPOLARIZATION OF AMINO ACID RESIDUES FOR PRODUCING HYPERPOLARIZED PEPTIDES | Feb 14, 2018 | Abandoned |
Array
(
[id] => 15083619
[patent_doc_number] => 20190336620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => NANOMATERIAL AND METHOD OF PRODUCTION OF A NANOMATERIAL FOR MEDICAL APPLICATIONS, SUCH AS MRI OR SERS
[patent_app_type] => utility
[patent_app_number] => 16/466379
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466379 | NANOMATERIAL AND METHOD OF PRODUCTION OF A NANOMATERIAL FOR MEDICAL APPLICATIONS, SUCH AS MRI OR SERS | Jan 25, 2018 | Abandoned |
Array
(
[id] => 15290871
[patent_doc_number] => 20190388571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/480107
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480107 | RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES | Jan 22, 2018 | Abandoned |
Array
(
[id] => 12676054
[patent_doc_number] => 20180117184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Quantum Dots for Diagnostic Imaging
[patent_app_type] => utility
[patent_app_number] => 15/853346
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853346
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853346 | Quantum Dots for Diagnostic Imaging | Dec 21, 2017 | Abandoned |
Array
(
[id] => 18962944
[patent_doc_number] => 11896683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Radiolabelled material for targeted administration
[patent_app_type] => utility
[patent_app_number] => 16/469244
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 24
[patent_no_of_words] => 20597
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469244 | Radiolabelled material for targeted administration | Dec 14, 2017 | Issued |
Array
(
[id] => 16353032
[patent_doc_number] => 10793533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/468035
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11950
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468035 | Dimeric contrast agents | Dec 10, 2017 | Issued |
Array
(
[id] => 18215311
[patent_doc_number] => 11590225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Bismuth-gadolinium nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/467698
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 33
[patent_no_of_words] => 13306
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467698 | Bismuth-gadolinium nanoparticles | Dec 7, 2017 | Issued |
Array
(
[id] => 17312963
[patent_doc_number] => 20210402011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => A COMPOUND FOR THE DETECTION OF HNO IN BIOLOGICAL SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/467842
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467842 | A COMPOUND FOR THE DETECTION OF HNO IN BIOLOGICAL SYSTEMS | Dec 4, 2017 | Abandoned |
Array
(
[id] => 15553613
[patent_doc_number] => 20200061218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Albumin-Binding PSMA Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/349756
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349756 | Albumin-binding PSMA inhibitors | Nov 23, 2017 | Issued |
Array
(
[id] => 17512616
[patent_doc_number] => 11291736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => pH-responsive ultrasensitive fluorescent nanoprobe, preparation and using method thereof
[patent_app_type] => utility
[patent_app_number] => 16/074778
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 4953
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074778 | pH-responsive ultrasensitive fluorescent nanoprobe, preparation and using method thereof | Nov 14, 2017 | Issued |